Expert Review of Clinical Immunology

Article	Citations
Pioglitazone as a potential modulator in autoimmune diseases: a review on its effects in systemic lupus erythematosus, psoriasis, inflammatory bowel disease, and multiple sclerosis	115
How could our genetics impact COVID-19 vaccine response?	89
Will SARS-CoV-2 impact the incidence and nature of other respiratory infections?	83
Pan-cancer analysis of the prognostic significance of ACKR2 expression and the related genetic/epigenetic dysregulations	69
The multidisciplinary approach to diagnosing inborn errors of immunity: a comprehensive review of discipline-based manifestations	62
Bradford Hill and breast implant illness: no evidence for causal association with breast implants	59
Full consideration of the pollen exposure effect in clinical trial design for pollen-induced allergic rhinitis	59
A critical review of dupilumab for adult patients with prurigo nodularis	54
Bimekizumab for the treatment of psoriatic arthritis	51
Aleukemic variant of T-cell large granular lymphocyte leukemia in patients with rheumatoid arthritis - diagnostically challenging subtype	37
Immunobiology and treatment of cutaneous T-cell lymphoma	35
The therapeutic effect of mRNA vaccines in glioma: a comprehensive review	33
A prospective single-arm study on the efficacy and safety of short-course oral corticosteroids followed by topical corticosteroids in patients with severe chronic rhinosinusitis with nasal polyps	33
IRF1 expression might be a biomarker of CD8+ T cell infiltration in cutaneous melanoma	32
The effect of intense pulsed light combined with topical 0.05% Cyclosporin A eyedrops in the treatment of Sjögren’s syndrome related dry eye	32
Ruxolitinib as the first post-steroid treatment for acute and chronic graft-versus-host disease	30
Pathogen-specific cell-mediated immunity to guide the management of cytomegalovirus in solid organ transplantation: state of the art clinical review	29
Food immunotherapy: current status and future needs	28
More than a random association between chronic obstructive pulmonary disease and psoriatic arthritis: shared pathogenic features and implications for treatment	27
How to and should we target EBV in MS?	27
Biomarkers guiding biological therapeutic strategies in chronic rhinosinusitis with nasal polyps: an emerging challenge	27
Dupilumab in chronic rhinosinusitis with nasal polyposis: current status, challenges, and future perspectives	26
Differential risk of autoimmune disorders in non-traumatic osteonecrosis: clue to pathogenesis	26
Emergence of an adaptive immune paradigm to explain celiac disease: a perspective on new evidence and implications for future interventions and diagnosis	22
Re-evaluation of nailfold capillaroscopy in discriminating primary from secondary Raynaud’s phenomenon and in predicting systemic sclerosis: a randomised observational prospective cohort study	22

Recent insights into the pathogenesis of autoimmune hypophysitis	22
Current treatment options and long-term outcomes in patients with eosinophilic esophagitis	21
Evaluating the use of JAK inhibitors in inflammatory connective tissue diseases in pediatric patients: an update	21
Advances in therapeutic targeting of immune checkpoints receptors within the CD96-TIGIT axis: clinical implications and future perspectives	20
Rare forms of inflammatory myopathies – part I, generalized forms	20
An exercise immune fitness test to unravel mechanisms of Post-Acute Sequelae of COVID-19	19
Pharmacokinetics and tolerability of prefilled syringe and auto-injector presentations of MSB11456: results of a randomized, single-dose study in healthy adults	19
Impact of anti-PD1 immunotherapy and circulating tumor cells on progression-free survival in surgical pancreatic adenocarcinoma: a retrospective cohort study	19
Transcriptional regulation of B cell class-switch recombination: the role in development of noninfectious complications	18
Durability and long-term outcomes of biologic therapies in psoriasis	18
How do nuclear factor kappa B (NF-κB)1 and NF-κB2 defects lead to the incidence of clinical and immunological manifestations of inborn errors of immunity?	18
Gut immune homeostasis: the immunomodulatory role of Bacillus clausii, from basic to clinical evidence	18
Direct economic burden 1 year postoperation in Chinese adult patients with chronic rhinosinusitis with nasal polyps	17
Neurological adverse effects of chimeric antigen receptor T-cell therapy	17
Pathophysiology and management of Staphylococcus aureus in nasal polyp disease	16
The functional role and the clinical application of periostin in chronic rhinosinusitis	16
Classification and management strategies for paediatric chronic nonbacterial osteomyelitis and chronic recurrent multifocal osteomyelitis	16
T-lymphocyte depleted transplants for inborn errors of immunity	15
CSE1L as a prognostic biomarker associated with pan cancer immune infiltration and drug sensitivity	15
Immune mechanisms, the role of complement, and related therapies in autoimmune neuropathies	15
Sicca syndrome/Sjögren’s disease associated with cancer immunotherapy: a narrative review on clinical presentation, biomarkers, and management	15
Novel insights into the pathogenesis of virus-induced ARDS: review on the central role of the epithelial-endothelial barrier	15
Advancements in immunotherapy for advanced esophageal squamous cell carcinoma: a comprehensive review of current strategies and future directions	15
An updated evaluation of avatrombopag for the treatment of chronic immune thrombocytopenia	14
Inflammatory myopathy in adults, health-related quality of life, and wellbeing: a round trip between immune disease and wellness	14
Transcriptomic observations of intra and extracellular immunotherapy targets for pediatric brain tumors	14
The role of interleukins in pathogenesis and prognosis of atrial fibrillation	14
Challenges in uncontrolled asthma in pediatrics: important considerations for the clinician	13
Recent insights into comorbidities in atopic dermatitis	13
Advances in tumor immunotherapy targeting macrophages	13
Perspectives for immunotherapy in noninfectious immune mediated uveitis	13
Recent updates in the diagnosis and management of cryoglobulinemic vasculitis	13
Patient-centered approaches for patients with systemic autoimmune rheumatic diseases: development and evolution	13
Safety of JAK inhibitors: focus on cardiovascular and thromboembolic events	13
Diagnostic accuracy of QuantiFERON-TB gold plus with chemiluminescence immunoassay: a systematic review and meta-analysis	13
Interferon beta-1a sc at 25 years: a mainstay in the treatment of multiple sclerosis over the period of one generation	12
Peanut allergy: risk factors, immune mechanisms, and best practices for oral immunotherapy success	12
Insights into the immunological links between dietary habits and asthma	12
Toward a personalized therapy of still’s disease based on immunologic endotypes: a narrative review	12
Subcutaneous immunoglobulin 16.5% for the treatment of pediatric patients with primary antibody immunodeficiency	11
At the cutting-edge: what’s the latest in imaging to diagnose Sjögren’s disease?	11
Harnessing the power of AI-based models to accelerate drug discovery against immune diseases	11
Glucocorticoid in systemic lupus erythematosus: the art beyond science	11
Updates in toxicities associated with immune checkpoint inhibitors	11
Monoclonal antibodies in diabetic retinopathy	11
Temporal trends in anaphylaxis ED visits over the last decade and the effect of COVID-19 pandemic on these trends	11
Current approaches for diagnosis of subclinical pulmonary tuberculosis, clinical implications and future perspectives: a scoping review	11
The interaction between innate immunity and oral microbiota in oral diseases	11
The role of serological biomarkers in the diagnosis and management of autoimmune pancreatitis	10
Guidance for stem cell therapy for juvenile systemic sclerosis patients	10

Hemophagocytic lymphohistiocytosis post chimeric antigen receptor T cell therapies	10
Skin infections during dupilumab monotherapy in moderate-to-severe atopic dermatitis – a meta-analysis of randomized clinical trials	10
Budesonide delayed-release capsules to reduce proteinuria in adults with primary immunoglobulin A nephropathy	10
The role of immune reconstitution in relapse after allogeneic hematopoietic stem cell transplantation	10
Induction of aquaporins by plasma of patients with systemic lupus erythematosus	10
Comparing available JAK inhibitors for treating patients with psoriasis	10
Pediatric IgG4-related disease: a descriptive review	10
Antiphospholipid antibodies and the risk of adverse pregnancy outcomes in patients with systemic lupus erythematosus: a systematic review and meta-analysis	10
Immunology and targeted therapy in Castleman disease	10
How does sleep influence asthma through immunity?	10
Basophil activation test in the food allergy clinic: its current use and future applications	10
Colorectal medullary carcinoma: a pathological subtype with intense immune response and potential to benefit from immune checkpoint inhibitors	10
Definition of severity and treatment response in chronic rhinosinusitis with nasal polyps: a Delphi study among French experts	10
Genetic polymorphisms impacting clinical pharmacology of drugs used to treat inflammatory bowel disease: a precursor to multi-omics approach to precision medicine	10
Gut-brain communication in COVID-19: molecular mechanisms, mediators, biomarkers, and therapeutics	10
Letter to the editor regarding ‘perspective: diagnostic laboratories should urgently develop T cell assays for SARS-CoV-2 infection’	10
B cell depletion and inhibition in systemic lupus erythematosus	10
What place will tezepelumab hold in the treatment paradigm in chronic rhinosinusitis?	10
Update on virus-induced asthma exacerbations	10
Abdeg technology for the treatment of myasthenia gravis: efgartigimod drug experience	10
Interleukin 6 in diabetes, chronic kidney disease, and cardiovascular disease: mechanisms and therapeutic perspectives	9
Risk of infections in psoriasis: assessment and challenges in daily management	9
Model-based computational precision medicine to develop combination therapies for autoimmune diseases	9
An evaluation of anifrolumab for use in adults with systemic lupus erythematosus	9
Systemic therapy in juvenile localized scleroderma	9
Epstein–Barr virus-driven lymphoproliferation in inborn errors of immunity: a diagnostic and therapeutic challenge	9
The (apparent) antibody paradox in COVID-19	9
A review of disease burden and clinical management for generalized pustular psoriasis in China	9
Tofacitinib for the treatment of active ankylosing spondylitis in adults	9
Treatment controversies in spondyloarthritis and psoriatic arthritis: focus on biologics and targeted therapies	9
Role of tight junction proteins in shaping the immune milieu of malignancies	9
Characterizing the immune tumor microenvironment in ALK fusion-positive lung cancer: state-of-the-art and therapeutical implications	9
Individual differences in response to dust-mite-allergen specific immunotherapy in allergic rhinitis: a meta-analysis of randomized controlled trials	9
An update on VEXAS syndrome	9
How suitable is intravenous tocilizumab for the treatment of Graves’ ophthalmopathy?	9
The clinical role of anakinra in the armamentarium against familial Mediterranean fever	9
Vascular endothelial dysfunction in pediatric rheumatic diseases: a systematic review and meta-analysis	8
Evaluating topical JAK inhibitors as a treatment option for atopic dermatitis	8
Biomarkers for systemic lupus erythematosus – a focus on organ damage	8
Late effects following hematopoietic cell transplantation for severe combined immunodeficiency: critical factors and therapeutic options	8
The suitability of treating atopic dermatitis with Janus kinase inhibitors	8
Considerations for managing elderly patients with atopic dermatitis	8
Treatment strategies for ANCA-associated vasculitides: from standard protocols to future horizons	8
Early diagnosis of systemic sclerosis, where do we stand today?	8
Clinical and immunologic implication of neo-osteogenesis in chronic rhinosinusitis	8
Management and treatment optimization of patients with mild to moderate ulcerative colitis	8
The role of PCSK9 in inflammation, immunity, and autoimmune diseases	8
The emerging role of IL-23 in asthma and its clinical implications	8
Response to letter to the editor: Bradford Hill and breast implant illness: evidence for a causal association with breast implants	8
AQP9 weakens the cytotoxicity of CD8 + T cells in colon adenocarcinoma by boosting M2 polarization of macrophages under hypoxia conditions	8
Efgartigimod for generalized myasthenia gravis with or without anti-acetylcholine receptor antibodies: a worldwide and Japanese perspective	8
Comorbid allergic rhinitis and asthma: important clinical considerations	7
Fatigue in ANCA-associated vasculitis (AAV) and systemic sclerosis (SSc): similarities with Myalgic encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). A critical review of the literature	7
Non-anti TNFα biologic agents for noninfectious uveitis associated with systemic inflammatory diseases: a systematic review	7
The GLP-1 receptor in airway inflammation in asthma: a promising novel target?	7
Development of a method of nasal secretions sampling for local nasal inflammation studies	7
The effect of immunotherapy on cross-reactivity between house dust mite and other allergens in house dust mite -sensitized patients with allergic rhinitis	7
Colchicine: protection of the brain beyond the heart?	7
Association between genetic variants in ZNF365 and inflammatory bowel disease risk in Caucasians: a meta-analysis and trial sequential analysis	7
Factors that influence infliximab biosimilar trough levels in the pediatric inflammatory bowel disease population	7
Cytokine alterations in psoriasis: an updated review	7
The role of systemic corticosteroids in severe asthma and new evidence in their management and tapering	7
A critical review of belumosudil in adult and pediatric patients with chronic graft-versus-host disease	7
Pharmacokinetics of a proposed tocilizumab biosimilar (MSB11456) versus US-licensed tocilizumab: results of a randomized, double-blind, single-intravenous dose study in healthy adults	7
An IPF-like disease course in disorders other than IPF: how can this be anticipated, recognized, and managed?	7
Recent issues in JAK inhibitor safety: perspective for the clinician	7
Resveratrol: immunological activity and possible application in children and adolescents with allergic rhinitis	7
The burden of mental health issues in Behçet’s disease: implications for patient quality of life	7
Comparative efficacy of systemic treatments for atopic dermatitis in adults	7
Cross-talk between immune cells and tumor cells in non-Hodgkin lymphomas arising in common variable immunodeficiency	7
The IL-4, IL-13 and IL-31 pathways in atopic dermatitis	7
In-vitro assays for immuno-oncology drug efficacy assessment and screening for personalized cancer therapy: scopes and challenges	7
Enthesitis-related arthritis and spondylarthritis: the same disease or disparate entities?	7
The CD8+ T cell exhaustion mechanisms in chronic hepatitis B infection and immunotherapeutic strategies: a systematic review	7
Is post-COVID syndrome an autoimmune disease?	7
Lack of association between TNFA and TNFB polymorphisms and the risk of multiple sclerosis: a meta-analysis from 37 studies	7
An evaluation of the recently approved drugs for treating atopic dermatitis in the context of their safety and efficacy: a systematic review and meta-analysis	6
Ex vivo and in vivo T-cell depletion in allogeneic transplantation: towards less or non-cytotoxic conditioning regimens	6
Innovative treatments for severe uncontrolled chronic rhinosinusitis with nasal polyps	6
Olfactory dysfunction in chronic rhinosinusitis: insights into the underlying mechanisms and treatments	6

Growth differentiation factor-15 as an emerging biomarker for identifying myositis	6
Re-envisioning clinical trial design in systemic sclerosis	6
Genetic syndromes and autoimmunity: what do we know? Focus on Down and Turner syndrome	6
IL-10: the master immunomodulatory cytokine in allergen immunotherapy	6
Inflammation resolution and specialized pro-resolving lipid mediators in chronic rhinosinusitis	6
The evolving role of JAK inhibitors in the treatment of inflammatory bowel disease	6
Managing acute COVID-19 in immunocompromised pediatric patients	6
Correction	6
Personalizing therapy selection in inflammatory bowel disease	6
Assessing the potential of epigenetic targets as biomarkers in the diagnosis and treatment of rheumatoid arthritis	6
Broadening the clinical spectrum of giant cell arteritis: from the classic cranial to the predominantly extracranial pattern of the disease	6
Why does malaise/fatigue occur? Underlying mechanisms and potential relevance to treatments in rheumatoid arthritis	6
The pathophysiology of MASLD: an immunometabolic perspective	6
COVID-19 and chronic rhinosinusitis: management and comorbidity – what have we learned?	6
Telemedicine beyond the pandemic: challenges in the pediatric immunology clinic	6
Pharmacokinetics and pharmacodynamics of a proposed tocilizumab biosimilar MSB11456 versus both the US-licensed and EU-approved products: a randomized, double-blind trial	6
The methylenetetrahydrofolate reductase 1298 A>C polymorphism is associated with an increased risk of inflammatory bowel disease: evidence from a meta-analysis	6
An updated review on Mendelian susceptibility to mycobacterial diseases– a silver jubilee celebration of its first genetic diagnosis	6
What is the full potential of baricitinib in treating patients with COVID-19?	6
Anifrolumab: first biologic approved in the EU not restricted to patients with a high degree of disease activity for the treatment of moderate to severe systemic lupus erythematosus	6
Biologicals for moderate-to-severe plaque type psoriasis in pediatric patients	6
Regulation of crystal induced inflammation: current understandings and clinical implications	6
Clinical and immunologic differences in cellulitis vs. pseudocellulitis	6
Thyroid eye disease in the biologic era: a 40-year paradigm shift in nonsurgical therapeutic strategies	6
A review of current biomarkers in chronic rhinosinusitis with or without nasal polyps	6
Epithelial cell dysfunction in chronic rhinosinusitis: the epithelial–mesenchymal transition	5
Clinical guide to eosinophilic fasciitis: straddling dermatology and rheumatology	5
5 reasons to encourage anti-SARS-CoV-2 vaccination in patients with rheumatic diseases	5
What is the relevance of FoxP3 in the tumor microenvironment and cancer outcomes?	5
Machine learning approaches to improve disease management of patients with rheumatoid arthritis: review and future directions	5
Presentation and diagnosis of autoimmune lymphoproliferative syndrome (ALPS)	5
Overcoming the challenges of primary resistance and relapse after CAR-T cell therapy	5
Preventing fibrosis in IBD: update on immune pathways and clinical strategies	5
Avacopan for the treatment of ANCA-associated vasculitis: an update	5
Single-cell RNA sequencing: an emerging tool revealing dysregulated innate and adaptive immune response at single cell level in Kawasaki disease	5
Pathological mechanisms of abnormal iron metabolism and mitochondrial dysfunction in systemic lupus erythematosus	5
Probiotics in asthma management: fiction or truth?	5
The role of complement and complement therapeutics in neuromyelitis optica spectrum disorders	5
Tumor-associated tertiary lymphoid structures in cancer: implications for immunotherapy	5
The oft-overlooked cardiovascular complications of inflammatory bowel disease	5
CAR-T cell technologies that interact with the tumour microenvironment in solid tumours	5
Innovative surgical approaches for chronic rhinitis: nasal neurectomy mechanisms, techniques, and clinical outcomes	5
Linking stress and inflammation – is there a missing piece in the puzzle?	5
New discoveries in the genetics and genomics of systemic juvenile idiopathic arthritis	5
Biologics for chronic spontaneous urticaria: toward a personalized treatment	5
Neuro-ophthalmic challenges and multi-morbidity in vasculitis among the older adults	5
Balancing risks and benefits in the use of hydroxychloroquine and glucocorticoids in systemic lupus erythematosus	5
A critical review of halobetasol propionate foam (0.05%) as a treatment option for adolescent plaque psoriasis	5
Recent insights into the impacts of COVID-19 on pediatric asthma	5
Ofatumumab subcutaneous injection for the treatment of relapsing forms of multiple sclerosis	5
Subcutaneous immunoglobulin 20% (Ig20Gly) treatment regimens in pediatric patients with primary immunodeficiencies – real-world data from the IG TATRY study	5
Conventional and new immunotherapies for immune system dysregulation in postpartum mood disorders: comparisons to immune system dysregulations in bipolar disorder, major depression, and postpartum aut	5
Comparing treatment options for large vessel vasculitis	5
Exploring the relationship between house dust mites and asthma	5
Efficacy comparison of immune treating strategies for NSCLC patients with negative PD-L1 expression	4
Causal role of immune cells in chronic obstructive pulmonary disease: Mendelian randomization study	4
Combination immunotherapy for pancreatic cancer: challenges and future considerations	4
Genes vs environment in inflammatory bowel disease: an update	4
Connecting salivary gland inflammation to specific symptoms in Sjögren’s disease	4
Chronic rhinosinusitis disease control: a review of the history and the evidence	4
Gut inflammation in CVID: causes and consequences	4
Evaluation of switching or simultaneous use of biologic treatment in patients with severe chronic rhinosinusitis with nasal polyps and severe asthma. Considerations in clinical decision making	4
Diagnostic methods and strategies for autoimmune bullous diseases	4
Do JAK inhibitors have a realistic future in treating Crohn’s disease?	4
Can we identify patients at risk of severe reactions to food?	4
Targeting the RANK/RANKL pathway in autoimmune disease and malignancy: future perspectives	4
Diagnosis and management of systemic sclerosis-related calcinosis	4
An update on biologic treatments for neuromyelitis optica spectrum disorder	4
Therapeutic potential of JAK inhibitors in juvenile idiopathic arthritis-associated uveitis	4
Upadacitinib for moderate-to-severe atopic dermatitis, in adults and adolescents 12 years and older: review of international and Japanese populations	4
Breast implant illness: scientific evidence of its existence	4
Novel biomarkers for prediction of outcome and therapeutic response in juvenile idiopathic arthritis	4
Spectrum of neurological manifestations, existence of diabetes mellitus, and 5-year mortality and cancer association outcomes in a cohort of Omani patients with positive anti- GAD autoimmunity	4
Translational impact of omics studies in alopecia areata: recent advances and future perspectives	4
Upadacitinib for the treatment of adults with active non-radiographic axial spondyloarthritis (nr-axSpA)	4
Janus kinase versus TNF inhibitors: where we stand today in rheumatoid arthritis	4
A review of berotralstat for the treatment of hereditary angioedema	4
Behçet disease: epidemiology, classification criteria and treatment modalities	4
The complex relationship between large granular lymphocyte leukemia and rheumatic disease	4
Secukinumab for the treatment of moderate-to-severe plaque psoriasis in paediatric patients aged six years and older	4
Future biomarkers for acute graft-versus-host disease: potential roles of nucleic acids, metabolites, and immune cell markers	3
Allergen immunotherapy: progress and future outlook	3
How suitable are JAK inhibitors in treating the inflammatory component in patients with alopecia areata and vitiligo?	3
Ten clinical conundrums in the management of eosinophilic granulomatosis with polyangiitis	3
Immune signatures, testing, and management of febrile neutropenia in pediatric cancer patients	3
How should we approach management of childhood onset chronic anterior uveitis refractory to adalimumab?	3
Correction	3
Diagnosis and clinical management of Wiskott–Aldrich syndrome: current and emerging techniques	3
Tumor associated macrophages as key contributors and targets in current and future therapies for melanoma	3
Correction	3
Response to letter to the editor: the clinical utility of diagnostic T cell assays for COVID-19	3
Ixekizumab: an IL-17A inhibitor for the treatment of axial Spondylarthritis	3
SLE criteria are by necessity still based on clinical (and immunological) criteria items	3
Real-world experience with subcutaneous infliximab: broadening treatment strategies for inflammatory bowel disease	3
A critical evaluation of suitability of tralokinumab for treatment of moderate-to-severe atopic dermatitis in adolescents and adults	3